Braskem (BAK) Other Accumulated Expenses (2009 - 2025)

Braskem (BAK) has reported Other Accumulated Expenses for 16 consecutive years, with $336.4 million the latest figure, recorded in Q1 2025.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $336.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $336.4 million (changed N/A YoY) and the FY2024 annual result came in at $358.9 million, down 19.3% from the prior year.
• Other Accumulated Expenses fell to $336.4 million in Q1 2025 per BAK's latest filing, from $358.9 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for BAK reached as high as $512.9 million in Q2 2024 and fell as low as $193.9 million in Q3 2021.
• A 4-year average of $369.4 million and a median of $358.9 million in 2024 frame the typical range for Other Accumulated Expenses.
• The largest YoY upside for Other Accumulated Expenses was 19.3% in 2024 against a maximum downside of 19.3% in 2024.
• Year by year, Other Accumulated Expenses stood at $193.9 million in 2021, then soared by 129.43% to $444.8 million in 2023, then dropped by 19.3% to $358.9 million in 2024, then decreased by 6.29% to $336.4 million in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $336.4 million, $358.9 million, and $512.9 million for Q1 2025, Q4 2024, and Q2 2024 respectively.